Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

How This Company Makes Money

Dividend Analysis BVXP

Max Ratio

34.27

Dividend Yield

7.89 %

5Y Dividend Growth

112.00 %

Consecutive Years

5Y Average Payout Ratio

91.49 %

Dividend History BVXP

1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021
Forward Annual Dividend Yield 7.89 %
Consecutive Years 0
Forward Annual Dividend 150.00 GBX
Consistent Years 0
Dividend CAGR 3Y 24.15 %
Continuous Dividends
Dividend CAGR 5Y 16.25 %
Payout Ratio TTM 81.63 %
Dividend CAGR 10Y 20.51 %
Ex Dividend Date 11/06/2025

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Financial Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

Sales Growth BVXP

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin BVXP

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income BVXP

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM BVXP

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio BVXP

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

Bioventix BVXP

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Bottom Line

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Peers

The company is measured against at least 10 rivals in the same sector. If it earns 25% more profit per share than the average, it’s Undervalued. If it earns 25% less, it’s Overvalued. In short: stronger earnings per share mean you’re getting a bargain, weaker ones mean you’re overpaying.

Value vs Itself BVXP

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE 13.29
Forward PE 13.59
Enterprise Value Revenue 6.98
Price Sales TTM 7.57
Enterprise Value EBITDA 9.01
Price Book MRQ 8.37

Bioventix Dividends: 7.89 % Yield, History, Payment Schedule

BVXP
Current price
1 900.00 GBX +50.02 GBX (+2.70%)
Last closed 1 850.00 GBX
ISIN GB00B4QVDF07
Sector Healthcare
Industry Biotechnology
Exchange London Exchange
Capitalization 99 501 055 GBX
Yield for 12 month -49.33 %
1Y
3Y
5Y
10Y
15Y
BVXP
11/21/2021 - 11/28/2021

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Advanced Highlights

Current Year

+1 314 609 014 GBX

Last Year

+1 363 793 594 GBX

Current Quarter

+674 786 768 GBX

Last Quarter

+694 715 850 GBX

Current Year

+1 194 445 042 GBX

Last Year

+1 271 027 630 GBX

Current Quarter

+592 754 933 GBX

Last Quarter

+641 824 239 GBX
EBITDA 10 189 841 GBX
Operating Margin TTM 79.24 %
Price to Earnings 13.29
Return On Assets TTM 47.35 %
PEG Ratio
Return On Equity TTM 64.40 %
Wall Street Target Price 292 305.39 GBX
Revenue TTM 13 146 090 GBX
Book Value 2.22 GBX
Revenue Per Share TTM
Dividend Share 1.50 GBX
Quarterly Revenue Growth YOY -7.90 %
Dividend Yield 7.89 %
Gross Profit TTM 11 944 451 GBX
Earnings per share 1.43 GBX
Diluted Eps TTM 1.43 GBX
Most Recent Quarter IV 2024
Quarterly Earnings Growth YOY -6.30 %
Profit Margin 57.83 %

Technical Indicators BVXP

For 52 Weeks

1 690.25 GBX 3 561.76 GBX
50 Day MA 2 209.28 GBX
Shares Short Prior Month
200 Day MA 2 540.39 GBX
Short Ratio
Shares Short
Short Percent